|
Jul 29
|
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
|
|
Jul 29
|
Universal Health Q2 Earnings Beat on Strong Acute Care Admissions
|
|
Jul 29
|
Here's Why Fresenius (FMS) is a Strong Value Stock
|
|
Jul 29
|
Is the Options Market Predicting a Spike in Fresenius Medical Stock?
|
|
Jul 24
|
Community Health Q2 Earnings Miss on Declining Patient Days
|
|
Jul 24
|
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs
|
|
Jul 21
|
FMS or SONVY: Which Is the Better Value Stock Right Now?
|
|
Jul 2
|
Centene Pulls 2025 Guidance as Marketplace Growth Falters
|
|
Jun 30
|
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
|
|
May 15
|
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
|
|
Mar 13
|
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum
|
|
Mar 3
|
Fresenius Seeks €1.1 Billion for Stake in Dialysis Company
|
|
Mar 3
|
Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.44
|
|
Feb 26
|
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y
|
|
Feb 26
|
Fresenius Medical Care AG (FMS) (Q4 2024) Earnings Call Highlights: Strong Operating Income ...
|
|
Feb 26
|
Germany's Fresenius tops profit estimates on strong drug unit performance
|
|
Feb 25
|
Fresenius Medical Care divests workforce by 8,200; sells Spectra assets
|
|
Feb 25
|
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
|
|
Feb 25
|
The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen
|
|
Feb 25
|
Dialysis firm FMC beats profit estimates in fourth quarter
|